Showing results (191-200 of 391) with videos related to

Sort By:
Pageof 40
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 1, 2024
Molecular and Clinical Portrait of HER2-low Invasive Lobular CarcinomasLounes Djerroudi, Ahmad El Sabeh-Ayoun, Camille Benoist, et al.
Carcinogenesis|October 24, 2013
A siRNA screen identifies RAD21, EIF3H, CHRAC1 and TANC2 as driver genes within the 8q23, 8q24.3 and 17q23 amplicons in breast cancer with effects on cell growth, survival and transformationSardar Faisal Mahmood, Nadège Gruel, Elodie Chapeaublanc, et al.
Advances in Radiation Oncology|March 18, 2024
Tolerance of Concurrent Adjuvant Radiation Therapy and Pembrolizumab for Triple Negative Breast Cancer: Real Life ExperienceThais Tison, Pierre Loap, Emilie Arnaud, et al.
Cancer Research|November 12, 2025
An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 UpregulationIsabella Hofer, Yann Kieffer, Arianna Mencattini, et al.
Breast Cancer Research : BCR|March 7, 2021
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patientsLauren Darrigues, Jean-Yves Pierga, Alice Bernard-Tessier, et al.
Plos One|October 22, 2013
Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomasAnne Vincent-Salomon, Vanessa Benhamo, Eléonore Gravier, et al.
Stem Cell Research & Therapy|April 24, 2022
PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injuryCharlotte Sarre, Rafael Contreras-Lopez, Nitirut Nernpermpisooth, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2024
EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across EuropeMichail Ignatiadis, Fiorita Poulakaki, Tanja Spanic, et al.
Clinical Chemistry|January 12, 2017
Patient-Specific Circulating Tumor DNA Detection during Neoadjuvant Chemotherapy in Triple-Negative Breast CancerFrancesca Riva, Francois-Clement Bidard, Alexandre Houy, et al.
JCO Precision Oncology|October 11, 2024
Fully Automated Artificial Intelligence Solution for Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Scoring in Breast Cancer: A Multireader StudySavitri Krishnamurthy, Stuart J Schnitt, Anne Vincent-Salomon, et al.
Pageof 40